MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Prelude Therapeutics Incorporated

PRLD

#2987
Prelude Therapeutics Incorporated
2.76
-5.80%
Sector:
Básica:
Profit Currency:
Rango diario
2.76
2.76
Rango anual
0.61
4.19
Cambio diario
-5.80%
Monthly Change
+28.37%
6 month change
+113.95%
Cambio anual
+253.85%
Cierres anteriores
2.93
Open
2.76
Bid
Ask
Low
2.76
High
2.76
Volumen
3
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. PRLD
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Investing Investing
PRLD
2026.02.04
Prelude Therapeutics: Citizens bestätigt "Market Outperform" und Kursziel von 3,00 $
Investing Investing
INCY PRLD
2026.02.04
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Investing Investing
PRLD
2026.02.03
Prelude Therapeutics: Aktie legt nach FDA-Zulassung für Krebsmedikament deutlich zu
Investing Investing
PRLD
2026.02.03
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Investing Investing
PRLD
2025.12.08
Prelude Therapeutics: Citizens bestätigt ’Market Outperform’-Rating
Investing Investing
PRLD
2025.12.08
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Investing Investing
INCY PRLD
2025.11.25
Incyte: Leiter des Rechnungswesens verkauft Aktien im Wert von 79.000 $
Zacks Zacks
GS-PA M AMGN MMM WDC
2025.11.24
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Investing Investing
INCY PRLD
2025.11.14
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Investing Investing
INCY PRLD
2025.11.12
Incyte-Aktie erreicht 52-Wochen-Hoch von 108,81 USD
Investing Investing
PRLD
2025.11.12
Prelude Therapeutics übertrifft im dritten Quartal die Gewinnerwartungen – Aktie zeigt sich stabil

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd